Understanding and Prevention of “Therapy-” Induced Dyskinesias by Iciar Aviles-Olmos, Zinovia Kefalopoulou, Thomas Foltynie

Get full text

Critical Aspects of Clinical Trial Design for Novel Cell and Gene Therapies by Zinovia Kefalopoulou, Iciar Aviles-Olmos, Thomas Foltynie

Get full text

Impairment in Theory of Mind in Parkinson’s Disease Is Explained by Deficits in Inhibition by Jennifer A. Foley, Claire Lancaster, Elena Poznyak, Olga Borejko, Elaine Niven, Thomas Foltynie, Sharon Abrahams, Lisa Cipolotti

Get full text

Decoding gripping force based on local field potentials recorded from subthalamic nucleus in humans by Huiling Tan, Alek Pogosyan, Keyoumars Ashkan, Alexander L Green, Tipu Aziz, Thomas Foltynie, Patricia Limousin, Ludvic Zrinzo, Marwan Hariz, Peter Brown

Get full text

POLR3A‐related disorders: From spastic ataxia to generalised dystonia and long‐term efficacy of deep brain stimulation by Wai Yan Yau, Catherine Ashton, Eoin Mulroy, Thomas Foltynie, Patricia Limousin, Jana Vandrovcova, Kunal P. Verma, Rick Stell, Mark Davis, Phillipa Lamont

Get full text

Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study by Thomas Foltynie, Thomas Payne, Iain D Wilkinson, Ellen Buckley, Claudia Mazza, Matilde Sassani, Sarah Moll, Adriana Anton, Matthew Appleby, Seema Maru, Rosie Taylor, Alisdair McNeill, N Hoggard, Thomas Jenkins, O Bandmann

Get full text

Computer vision quantification of whole-body Parkinsonian bradykinesia using a large multi-site population by Gareth Morinan, Yuriy Dushin, Grzegorz Sarapata, Samuel Rupprechter, Yuwei Peng, Christine Girges, Maricel Salazar, Catherine Milabo, Krista Sibley, Thomas Foltynie, Ioana Cociasu, Lucia Ricciardi, Fahd Baig, Francesca Morgante, Louise-Ann Leyland, Rimona S. Weil, Ro’ee Gilron, Jonathan O’Keeffe

Get full text

Development and clinimetric assessment of a nurse-administered screening tool for movement disorders in psychosis by Bettina Balint, Helen Killaspy, Louise Marston, Thomas Barnes, Anna Latorre, Eileen Joyce, Caroline S. Clarke, Rosa De Micco, Mark J. Edwards, Roberto Erro, Thomas Foltynie, Rachael M. Hunter, Fiona Nolan, Anette Schrag, Nick Freemantle, Yvonne Foreshaw, Nicholas Green, Kailash P. Bhatia, Davide Martino

Get full text

Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study. by Alastair J Noyce, Demis A Kia, Gibran Hemani, Aude Nicolas, T Ryan Price, Eduardo De Pablo-Fernandez, Philip C Haycock, Patrick A Lewis, Thomas Foltynie, George Davey Smith, International Parkinson Disease Genomics Consortium, Anette Schrag, Andrew J Lees, John Hardy, Andrew Singleton, Mike A Nalls, Neil Pearce, Debbie A Lawlor, Nicholas W Wood

Get full text

Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson’s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo... by Thomas Foltynie, Rachael Hunter, Lynn Rochester, Dilan Athauda, Patricia Limousin, Alexa King, Simon Skene, Kashfia Chowdhury, Camille B Carroll, Huw Morris, Michele T Hu, Monty Silverdale, Rachel Gibson, Marisa Chau, Christine Lo, Nirosen Vijiaratnam, Christine Girges, Grace Auld, Kate Maclagan, Steve Hibbert, Gordon W Duncan, Ray Chaudhuri, Silvia Del Din, Alison J Yarnall, John Dickson, Vincenzo Libri

Get full text

Genome-wide determinants of mortality and motor progression in Parkinson’s disease by Manuela M. X. Tan, Michael A. Lawton, Miriam I. Pollard, Emmeline Brown, Raquel Real, Alejandro Martinez Carrasco, Samir Bekadar, Edwin Jabbari, Regina H. Reynolds, Hirotaka Iwaki, Cornelis Blauwendraat, Sofia Kanavou, Leon Hubbard, Naveed Malek, Katherine A. Grosset, Nin Bajaj, Roger A. Barker, David J. Burn, Catherine Bresner, Thomas Foltynie, Nicholas W. Wood, Caroline H. Williams-Gray, Ole A. Andreassen, Mathias Toft, Alexis Elbaz, Fanny Artaud, Alexis Brice, Jean-Christophe Corvol, Jan Aasly, Matthew J. Farrer, Michael A. Nalls, Andrew B. Singleton, Nigel M. Williams, Yoav Ben-Shlomo, John Hardy, Michele T. M. Hu, Donald G. Grosset, Maryam Shoai, Lasse Pihlstrøm, Huw R. Morris

Get full text

Genotype–phenotype correlation in PRKN-associated Parkinson’s disease by Poornima Jayadev Menon, Sara Sambin, Baptiste Criniere-Boizet, Thomas Courtin, Christelle Tesson, Fanny Casse, Melanie Ferrien, Louise-Laure Mariani, Stephanie Carvalho, Francois-Xavier Lejeune, Sana Rebbah, Gaspard Martet, Marion Houot, Aymeric Lanore, Graziella Mangone, Emmanuel Roze, Marie Vidailhet, Jan Aasly, Ziv Gan Or, Eric Yu, Yves Dauvilliers, Alexander Zimprich, Volker Tomantschger, Walter Pirker, Ignacio Álvarez, Pau Pastor, Alessio Di Fonzo, Kailash P. Bhatia, Francesca Magrinelli, Henry Houlden, Raquel Real, Andrea Quattrone, Patricia Limousin, Prasad Korlipara, Thomas Foltynie, Donald Grosset, Nigel Williams, Derek Narendra, Hsin-Pin Lin, Carna Jovanovic, Marina Svetel, Timothy Lynch, Amy Gallagher, Wim Vandenberghe, Thomas Gasser, Kathrin Brockmann, Huw R. Morris, Max Borsche, Christine Klein, Olga Corti, Alexis Brice, Suzanne Lesage, Jean Christophe Corvol, French Parkinson disease Genetics Study Group (PDG)

Get full text